A novel imaging technique using prostate-specific membrane antigen

A novel imaging technique using prostate-specific membrane antigen (PSMA) is superior to conventional imaging for staging men with high-risk prostate cancer, according to a phase 3 trial conducted in Australia and published in the Lancet.